The firm's analysts think highly of Target's long-term prospects, despite cutting their price target for the fifth time since ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

An assessment by UBS says Bristol Myers Squibb and Pfizer would be worst hit among US companies if Mr Trump’s threatened ...

Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

U.S.-based LNG company New Fortress Energy said on Tuesday it would push its quarterly filing with the U.S. securities ...